| Prevalence of Barrett’s esophagus and esophageal adenocarcinoma with and without gastroesophageal reflux: a systematic review and meta-analysis B Saha, K Vantanasiri, BP Mohan, R Goyal, N Garg, D Gerberi, JB Kisiel, ... Clinical Gastroenterology and Hepatology 22 (7), 1381-1394. e7, 2024 | 14 | 2024 |
| Clinical outcomes after endoscopic management of low-risk and high-risk t1a esophageal adenocarcinoma: a multicenter study AK Kamboj, R Goyal, K Vantanasiri, K Sachdeva, M Passe, R Lansing, ... Official journal of the American College of Gastroenterology| ACG 119 (4 …, 2024 | 6 | 2024 |
| RATES OF RECURRENT INTESTINAL METAPLASIA AND DYSPLASIA AFTER SUCCESSFUL ENDOSCOPIC THERAPY OF BARRETT'S NEOPLASIA BY CAP ASSISTED EMR VS ESD AND ABLATION: RESULTS FROM A LARGE … K Vantanasiri, A Joseph, K Sachdeva, R Goyal, N Garg, D Codipilly, ... Gastrointestinal Endoscopy 97 (6), AB976-AB977, 2023 | 4 | 2023 |
| Demographic and KAP determinants of COVID-19 vaccine hesitancy and vaccine refusal: a cross-sectional study in Indian population M Gupta, R Goyal, S Aggarwal, M Singh, V Gupta, N Garg Int J Community Med Public Health 8 (10), 4776, 2021 | 3 | 2021 |
| Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists R Goyal, AK Kamboj, DL Snyder Mayo Clinic Proceedings 99 (4), 640-648, 2024 | 1 | 2024 |
| JOURNEY TO COMPLETE REMISSION OF DYSPLASIA AND INTESTINAL METAPLASIA AFTER ENDOSCOPIC ERADICATION THERAPY OF BARRETT’S ESOPHAGUS RELATED DYSPLASIA AND ADENOCARCINOMA: A … A Joseph, K Vantanasiri, R Goyal, N Garg, C Leggett, D Codipilly, ... Gastrointestinal Endoscopy 97 (6), AB975-AB976, 2023 | 1 | 2023 |
| Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett’s Neoplasia by EMR vs ESD and Ablation: A Large North American Multicenter … K Vantanasiri, A Joseph, K Sachdeva, R Goyal, N Garg, D Adoor, ... Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022 | 1 | 2022 |
| Mo1045 ASSESSING HEALTHCARE ACCESS HURDLES FACED BY INDIVIDUALS WITH COLON CANCER: A NATIONAL HEALTH INTERVIEW SURVEY K Sachdeva, LS Dhaliwal, R Goyal, A Vyas, D Raza, S Pandit Gastroenterology 166 (5), S-927-S-928, 2024 | | 2024 |
| Tu1244 CHRONIC OPIATE USERS DEMONSTRATE OBSTRUCTIVE FEATURES ON FUNCTIONAL LUMEN IMAGING PROBE DESPITE NORMAL MOTILITY OR INEFFECTIVE ESOPHAGEAL MOTILITY ON HIGH RESOLUTION … DL Snyder, R Goyal, D Patel, MG Rubeiz, BD Rogers, MF Vela, ... Gastroenterology 166 (5), S-1297-S-1298, 2024 | | 2024 |
| Tu1026 UTILIZATION AND IMPACT OF HEALTH INFORMATION TECHNOLOGY AMONG GASTRO-INTESTINAL CANCER PATIENTS: A NATIONAL HEALTH INTERVIEW SURVEY STUDY K Sachdeva, LS Dhaliwal, R Goyal, D Raza, A Vyas, S Pandit Gastroenterology 166 (5), S-1226-S-1227, 2024 | | 2024 |
| Sa1038 EXPLORING DISPARITIES: IMPACT OF RACE AND ETHNICITY ON HOSPITALIZATION OUTCOMES IN CIRRHOTIC PATIENTS WITH VACCINE-PREVENTABLE DISEASES K Sachdeva, LS Dhaliwal, A Vyas, R Goyal, D Raza, S Pandit Gastroenterology 166 (5), S-331, 2024 | | 2024 |
| Su1258 OUTCOMES OF ENDOSCOPIC ERADICATION THERAPY IN PATIENTS WITH YOUNG-ONSET BARRETT'S ESOPHAGUS. SLA Perneth, S Bhattarai, R Goyal, MK Yarlagadda, A Kamboj, ... Gastroenterology 166 (5), S-712, 2024 | | 2024 |
| Echocardiographic Coronary Flow Velocity Parameters in Assessing Sub-Clinical Atherosclerosis in Inflammatory Bowel Disease Patients: A Meta-Analysis V Sharma, abhigan babu Shrestha, A Malhotra, S Agarwal, H Kumar, ... Circulation 148 (Suppl_1), A13363-A13363, 2023 | | 2023 |
| S1020 Evaluating Subclinical Atherosclerosis Using Vascular Parameters in Inflammatory Bowel Disease Patients: A Meta-Analysis V Sharma, R Yadav, CK Dash, R Goyal, S Dang, H Kumar, N Garg, ... Official journal of the American College of Gastroenterology| ACG 118 (10S …, 2023 | | 2023 |
| TIME TRENDS, MANAGEMENT AND OUTCOMES OF PATIENTS UNDERGOING COMMUNITY ENDOSCOPIC THERAPY FOR DYSPLASTIC BARRETT'S ESOPHAGUS BEFORE REFERRAL TO A HIGH VOLUME BARRETT'S … N Garg, R Goyal, K Vantanasiri, W Harmsen, K Sachdeva, L Dhaliwal, ... Gastrointestinal Endoscopy 97 (6), AB1117, 2023 | | 2023 |
| CLINICAL OUTCOMES AFTER ENDOSCOPIC MANAGEMENT OF LOW-RISK AND HIGH-RISK T1A ESOPHAGEAL ADENOCARCINOMA: OUTCOMES FROM A LARGE COHORT A Kamboj, R Goyal, K Vantanasiri, K Sachdeva, E Gibbons, M Passe, ... Gastrointestinal Endoscopy 97 (6), AB973-AB974, 2023 | | 2023 |
| Tu1275 SPECTRUM AND IMPACT OF COMMUNITY BARRETT'S ESOPHAGUS HISTOLOGY SENT FOR EXPERT US ACADEMIC PATHOLOGY REVIEW N Garg, R Goyal, K Vantanasiri, DC Codipilly, E Gibbons, R Lansing, ... Gastroenterology 164 (6), S-1015, 2023 | | 2023 |
| Tu1276 PREVALENCE OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX SYMPTOMS: A SYSTEMATIC REVIEW AND META-ANALYSIS B Saha, K Vantanasiri, BP Mohan, R Goyal, N Garg, D Gerberi, S Singh, ... Gastroenterology 164 (6), S-1015-S-1016, 2023 | | 2023 |
| Mo1290 FUNCTIONAL LUMEN IMAGING PROBE FINDINGS IN CHRONIC OPIOID USERS COMPARED TO SYMPTOMATIC NON-OPIOID USERS R Goyal, DL Snyder, DC Codipilly, K Ravi, A Koop, MF Vela Gastroenterology 164 (6), S-817, 2023 | | 2023 |
